<DOC>
	<DOCNO>NCT00288652</DOCNO>
	<brief_summary>The purpose study determine effectiveness different dos [ S , S ] -Reboxetine treatment chronic pain follow shingle infection</brief_summary>
	<brief_title>S , S-Reboxetine Dose-Range Finding Trial</brief_title>
	<detailed_description />
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Patients must pain present 3 month heal shingle skin rash Patients screen must score &gt; /=40 mm pain visual analogue scale Patients significant renal hepatic impairment Patients severe pain , may impair selfassessment pain due shingle Patients clinically abnormal electrocardiogram</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>